Insider Trading & Ownership of GSK plc

Location
London
Summary
The estimated value of insider holdings of GSK plc is at least $446M dollars as of 15 Dec 2025. GSK plc is the 10%+ Owner of Wave Life Sciences Ltd. and owns shares of Wave Life Sciences Ltd. (WVE) stock worth about $347M. GSK plc is the 10%+ Owner of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $69M. GSK plc is the 10%+ Owner of CVRx, Inc. and owns shares of CVRx, Inc. (CVRX) stock worth about $18.7M. GSK plc is the 10%+ Owner of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $11.7M.
Signature
/s/ Victoria Whyte, Authorized Signatory, GSK plc
All Insider Reports
All Insider Reports

Notify me when GSK plc files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of GSK plc

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
WVE Wave Life Sciences Ltd. 10%+ Owner $347M +$27.9M +8.76% 11 Dec 2025
LYEL Lyell Immunopharma, Inc. 10%+ Owner $69M 21 Jun 2021
CVRX CVRx, Inc. 10%+ Owner $18.7M 02 Jul 2021
SPRO Spero Therapeutics, Inc. 10%+ Owner $11.7M 07 Nov 2022
MEHCQ 23andMe Holding Co. 10%+ Owner 16 Jun 2021
INVA Innoviva, Inc. 10%+ Owner 20 May 2021
TBPH Theravance Biopharma, Inc. Former 10% Owner 16 Sep 2022

Insider Transactions Reported by GSK plc:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.